ProMark Risk Score

Summary of Evidence Analysis of Evidence General Information Associated Information Sources of Information Bibliography Revision History Information Associated Documents Attachments Related Local Coverage Documents Related National Coverage Documents Public Versions Keywords Local Coverage Determination (LCD) ProMark® Risk Score L36665 Expand All | Collapse All  Email Document  Download  Add to basket Contractor Information Contractor Name Contract Type Contract Number Jurisdiction States LCD Information Document Information LCD ID L36665 LCD Title ProMark® Risk Score Proposed LCD in Comment Period N/A Source Proposed LCD DL36665 Original Effective Date For services performed on or after 10/10/2016 Revision Effective Date For services performed on or after 12/30/2021 Revision Ending Date N/A Retirement Date N/A Notice Period Start Date 08/23/2018 Notice Period End Date 10/07/2018 CPT codes, descriptions, and other data only are copyright 2025 American Medical Association. All Rights Reserved. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are no

This Contractor will provide limited coverage for the ProMark ® (Metamark Genetics) to help determine which patients with early stage, needle biopsy proven prostate cancer can be conservatively managed rather than treated with definitive surgery or radiation therapy.